Becton Dickinson & Co. header image

Becton Dickinson & Co.

BDX

Equity

ISIN null / Valor 912061

New York Stock Exchange, Inc (2026-08-06)
USD 177.07+3.76%

Becton Dickinson & Co.
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Becton Dickinson & Co. (BD) is a long-established, publicly traded medical technology company headquartered in Franklin Lakes, New Jersey, that designs, manufactures and sells a broad range of medical devices, instrument systems and diagnostic products for healthcare institutions, clinical laboratories, life sciences researchers and pharmaceutical manufacturers. Its offerings include needles and syringes, infusion and medication-delivery systems, catheter and vascular access devices, prefillable drug-delivery systems and related pharmaceutical manufacturing services, as well as diagnostic instruments, specimen collection and preanalytical systems and reagents used in clinical and molecular diagnostics. BD operates globally across multiple business units that serve hospitals, outpatient facilities, labs and biopharma customers, combining product sales with service and technical support for clinical and research workflows.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

2.70%1Y
-34.6%3Y
-26.5%5Y

Performance

32.2%1Y
27.8%3Y
25.4%5Y

Volatility

Market cap

48790 M

Market cap (USD)

Daily traded volume (Shares)

3,297,360

Daily traded volume (Shares)

1 day high/low

227.8 / 225.05

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Ramsay Generale de Sante SA
Ramsay Generale de Sante SA Ramsay Generale de Sante SA Valor: 1247709
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 10.90
Robertet SA
Robertet SA Robertet SA Valor: 510354
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.25%EUR 808.00
MEDICLIN AG
MEDICLIN AG MEDICLIN AG Valor: 1158721
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.31%EUR 4.22
Ste Virbac SA
Ste Virbac SA Ste Virbac SA Valor: 524407
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.48%EUR 343.50
Orion Oyj
Orion Oyj Orion Oyj Valor: 2553367
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.31%EUR 81.60
Terveystalo Oyj
Terveystalo Oyj Terveystalo Oyj Valor: 37893402
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.53%EUR 7.56
RadNet Inc
RadNet Inc RadNet Inc Valor: 2812237
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.64%USD 68.16
Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC Valor: 2324471
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
8.15%GBP 16.99
Pharma Mar SA
Pharma Mar SA Pharma Mar SA Valor: 56130572
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.84%EUR 77.70
Alnylam Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc Alnylam Pharmaceuticals Inc Valor: 1806798
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.51%USD 216.12